STOCK TITAN

[Form 4] COHEN & STEERS, INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Karen Wilson Thissen, a director of Cohen & Steers, Inc. (CNS), received an award of 423 restricted stock units on 10/01/2025. The filing shows the RSUs were 100% vested on the grant date and will be delivered in shares to Ms. Thissen Wilson on the third anniversary of the grant. The Form 4 reports an acquisition price of $0 for the award and that the reporting person beneficially owns 1,302 shares of common stock following the transaction. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Karen Wilson Thissen, una direttrice di Cohen & Steers, Inc. (CNS), ha ricevuto un premio di 423 unità di azioni vincolate (RSU) il 01/10/2025. Il fascicolo mostra che le RSU erano completamente maturate al momento della concessione e saranno consegnate in azioni alla Signora Thissen Wilson nel terzo anniversario della concessione. Il Modulo 4 riporta un prezzo di acquisizione di $0 per l’assegnazione e che la persona che riporta detiene in modo beneficiario 1.302 azioni di azioni ordinarie a seguito della transazione. Il Modulo 4 è stato firmato da un procuratore fatto per conto della persona che riporta.

Karen Wilson Thissen, una directora de Cohen & Steers, Inc. (CNS), recibió una asignación de 423 Unidades de Acciones Restringidas (RSU) el 01/10/2025. El archivo indica que las RSU estaban vestidas al 100% en la fecha de adjudicación y serán entregadas en acciones a la Sra. Thissen Wilson en el tercer aniversario de la adjudicación. El Formulario 4 reporta un precio de adquisición de $0 para la adjudicación y que la persona que informa posee de manera beneficiosa 1.302 acciones comunes tras la transacción. El Formulario 4 fue firmado por un apoderado en nombre de la persona que informa.

Karen Wilson Thissen, Cohen & Steers, Inc. (CNS)이사로, 423개의 제한 주식 단위(RSU) 상을 2025년 10월 1일에 받았습니다. 서류에 RSU가 부여일에 전부 권리 행사되었고, 부여의 3주년에 Thissen Wilson 양에게 주식으로 전달될 예정이라고 표시되어 있습니다. Form 4는 상여의 매수가격이 $0이고 거래 후 보고자의 실제 보유주식 수가 1,302주임을 보고합니다. Form 4는 보고를 받는 사람을 대신하여 대리인이 서명했습니다.

Karen Wilson Thissen, une directrice de Cohen & Steers, Inc. (CNS), a reçu une attribution de 423 unités d’actions restreintes (RSU) le 01/10/2025. Le dépôt indique que les RSU étaient vested à 100% à la date d’attribution et seront livrées sous forme d’actions à Mme Thissen Wilson lors du troisième anniversaire de l’attribution. Le Formulaire 4 indique un prix d’acquisition de $0 pour cette attribution et que la personne déclarante détient de manière bénéficiaire 1 302 actions ordinaires à la suite de la transaction. Le Formulaire 4 a été signé par un mandataire au nom de la personne déclarante.

Karen Wilson Thissen, eine Direktorin von Cohen & Steers, Inc. (CNS), erhielt am 01.10.2025 eine Zuteilung von 423 Restricted Stock Units (RSUs). Die Einreichung zeigt, dass die RSUs zum Zeitpunkt der Gewährung zu 100% vestet waren und auf Frau Thissen Wilson am dritten Jahrestag der Gewährung in Aktien geliefert werden. Das Formular 4 meldet einen Erwerbspreis von $0 für die Zuteilung und dass die meldende Person nach der Transaktion 1.302 Stammaktien vorteilhaft besitzt. Das Formular 4 wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

Karen Wilson Thissen، مديرة في Cohen & Steers, Inc. (CNS)، تلقت مكافأة قدرها 423 وحدة أسهم مقيدة (RSUs) في 01/10/2025. يُظهر الإيداع أن RSUs كانت الاستحقاق بنسبة 100% في تاريخ المنح، وستُسلَّم على شكل أسهم للسيدة Thissen Wilson في الذكرى الثالثة للمنح. يبلغ النموذج 4 عن سعر الاستحواذ $0 لهذه الجائزة وأن الشخص المبلغ يمتلك فعلياً 1,302 سهماً من الأسهم العادية عقب الصفقة. تم توقيع النموذج 4 من قبل وكيل نيابة نيابة باسم الشخص المبلغ.

Karen Wilson ThissenCohen & Steers, Inc. (CNS)董事,在 2025/10/01 收到一份价值 423 的受限股票单位(RSU)奖酬。文件显示 RSU 在授予日已 100% 授权/归属,将在授予日后的 第三周年 时以股票形式交付给 Thissen Wilson 女士。Form 4 报告该奖酬的取得价格为 $0,并且该申报人交易后实际拥有 1,302 股普通股。Form 4 由一名代理律师代表申报人签署。

Positive
  • 423 RSUs granted to a director, aligning compensation with shareholder interests
  • 100% vested on grant date, indicating no further service condition to vesting
Negative
  • Delivery deferred until the third anniversary, delaying actual share receipt and liquidity

Insights

Director received 423 RSUs, vested on grant with delivery delayed three years.

The Form 4 discloses a grant of 423 restricted stock units to Karen Wilson Thissen on 10/01/2025 that were 100% vested at grant but are contractually payable on the third anniversary of the grant date.

Because the RSUs carry an acquisition price of $0 and add to the director's total beneficial ownership of 1,302 shares, the award aligns executive compensation with shareholder exposure while preserving a retention/timing element via delayed delivery.

Karen Wilson Thissen, una direttrice di Cohen & Steers, Inc. (CNS), ha ricevuto un premio di 423 unità di azioni vincolate (RSU) il 01/10/2025. Il fascicolo mostra che le RSU erano completamente maturate al momento della concessione e saranno consegnate in azioni alla Signora Thissen Wilson nel terzo anniversario della concessione. Il Modulo 4 riporta un prezzo di acquisizione di $0 per l’assegnazione e che la persona che riporta detiene in modo beneficiario 1.302 azioni di azioni ordinarie a seguito della transazione. Il Modulo 4 è stato firmato da un procuratore fatto per conto della persona che riporta.

Karen Wilson Thissen, una directora de Cohen & Steers, Inc. (CNS), recibió una asignación de 423 Unidades de Acciones Restringidas (RSU) el 01/10/2025. El archivo indica que las RSU estaban vestidas al 100% en la fecha de adjudicación y serán entregadas en acciones a la Sra. Thissen Wilson en el tercer aniversario de la adjudicación. El Formulario 4 reporta un precio de adquisición de $0 para la adjudicación y que la persona que informa posee de manera beneficiosa 1.302 acciones comunes tras la transacción. El Formulario 4 fue firmado por un apoderado en nombre de la persona que informa.

Karen Wilson Thissen, Cohen & Steers, Inc. (CNS)이사로, 423개의 제한 주식 단위(RSU) 상을 2025년 10월 1일에 받았습니다. 서류에 RSU가 부여일에 전부 권리 행사되었고, 부여의 3주년에 Thissen Wilson 양에게 주식으로 전달될 예정이라고 표시되어 있습니다. Form 4는 상여의 매수가격이 $0이고 거래 후 보고자의 실제 보유주식 수가 1,302주임을 보고합니다. Form 4는 보고를 받는 사람을 대신하여 대리인이 서명했습니다.

Karen Wilson Thissen, une directrice de Cohen & Steers, Inc. (CNS), a reçu une attribution de 423 unités d’actions restreintes (RSU) le 01/10/2025. Le dépôt indique que les RSU étaient vested à 100% à la date d’attribution et seront livrées sous forme d’actions à Mme Thissen Wilson lors du troisième anniversaire de l’attribution. Le Formulaire 4 indique un prix d’acquisition de $0 pour cette attribution et que la personne déclarante détient de manière bénéficiaire 1 302 actions ordinaires à la suite de la transaction. Le Formulaire 4 a été signé par un mandataire au nom de la personne déclarante.

Karen Wilson Thissen, eine Direktorin von Cohen & Steers, Inc. (CNS), erhielt am 01.10.2025 eine Zuteilung von 423 Restricted Stock Units (RSUs). Die Einreichung zeigt, dass die RSUs zum Zeitpunkt der Gewährung zu 100% vestet waren und auf Frau Thissen Wilson am dritten Jahrestag der Gewährung in Aktien geliefert werden. Das Formular 4 meldet einen Erwerbspreis von $0 für die Zuteilung und dass die meldende Person nach der Transaktion 1.302 Stammaktien vorteilhaft besitzt. Das Formular 4 wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
THISSEN KAREN WILSON

(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 A 423(1) A $0 1,302 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.
Remarks:
/s/ Brian W. Heller, Attorney-in-Fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for Cohen & Steers (CNS) disclose?

The Form 4 shows director Karen Wilson Thissen was granted 423 restricted stock units on 10/01/2025 and beneficially owns 1,302 common shares.

Were the RSUs immediately vested for Karen Thissen Wilson?

Yes. The filing states the restricted stock units were 100% vested on the grant date.

When will the RSUs be delivered as shares?

The related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

What price was paid for the RSU award?

The transaction is reported with an acquisition price of $0, consistent with a grant of RSUs.

Who signed the Form 4 filing?

The filing bears the signature of Brian W. Heller, Attorney-in-Fact dated 10/03/2025.
Cohen & Steers Inc

NYSE:CNS

CNS Rankings

CNS Latest News

CNS Latest SEC Filings

CNS Stock Data

3.32B
27.43M
46.02%
60.33%
3.88%
Asset Management
Investment Advice
Link
United States
NEW YORK